Ascendis Pharma has piqued my interest due to its promising developments and strong pipeline. The company boasts several commercial stage products ... TransCon CNP is shooting for approval ...

From Ben Affleck's DunKings to David Beckham and his long-lost twin Dave (played by Matt Damon) and all the pop star ...

At a time when every fresh news alert seems to deliver a new seismic jolt about the world – the ads featured in this year's Super Bowl mostly touch on safe subjects we traditionally expect in Big Game ...

US government could seek over $1 billion from J&J for cancer treatment costs Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits ...

Bryan O’Donnell, Head of Quality at Gaelic Laboratories, explains how to navigate GMP challenges to ensure your company ...

New service ensures rapid delivery of small volume clinical trial materials, solving a critical bottleneck in drug ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

Expected to be listed in the U.S. Food and Drug Administration’s (FDA) Orange Book upon the product’s approval – DEER PARK, Ill., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, ...

“Companies are realizing that investing stateside can provide more control and resilience to the drug supply chain,” says Dymowski. She cites political tensions, import and export disruptions, and ...

D.C.’s Vanda Pharmaceuticals Inc. has locked in a deal with a West Coast biotech to commercialize a drug for a rare skin ...

but Sionna Therapeutics contends the pharma company’s products still have efficacy and safety limitations. Sionna has mapped out a clinical trial strategy that could validate its different ...

Journavx is one of three recently approved drugs in Vertex Pharmaceuticals' product lineup. The U.S. Food and Drug Administration (FDA) approved suzetrigine under the brand name Journavx on Jan ...